BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study
| Autor: | Elamin, Y., Nagasaka, M., Shum, E., Bazhenova, L., Rotow, J., Spigel, D.R., Tan, D.S.W., Zalutskaya, A., Albayya, F., Reckamp, K.L. |
|---|---|
| Zdroj: | In The Journal of Liquid Biopsy November 2023 1 Supplement |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|